Changes in the clinical and epidemiological features of group A streptococcal bacteraemia in Australia's Northern Territory

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Tropical medicine & international health

• Publication date

  2015-01-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1111/tmi.12405PMID 25354844
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Invasive group A streptococcal disease

  2024cited by this paper
• World Health Report

  2013cited by this paper
• Invasive Group A Streptococcal Disease

  2012cited by this paper
• Sepsis in the tropical Top End of Australia's Northern Territory: disease burden and impact on Indigenous Australians

  2011influential reference
• Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998–2009): comparison with non-invasive isolates

  2011influential reference
• Invasive group A streptococcal infections in adults, France (2006-2010).

  2011influential reference
• Increase in invasive Streptococcus pyogenes and Streptococcus pneumoniae infections in England, December 2010 to January 2011.

  2011cited by this paper
• Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007.

  2010influential reference
• Invasive group A streptococcal disease in children in Queensland

  2010influential reference
• Prospective Surveillance of Invasive Group A Streptococcal Disease, Fiji, 2005–2007

  2009influential reference
• Indigenous health part 1: determinants and disease patterns.

  2009cited by this paper
• Global emm type distribution of group A streptococci: systematic review and implications for vaccine development.

  2009influential reference
• High burden of invasive beta-haemolytic streptococcal infections in Fiji.

  2008cited by this paper
• Epidemiology of Severe Streptococcus pyogenes Disease in Europe

  2008cited by this paper
• The state of health hardware in Aboriginal communities in rural and remote Australia

  2008cited by this paper
• The epidemiology of invasive group A streptococcal disease in Victoria, Australia

  2007influential reference
• [Invasive streptococcal infections].

  2007cited by this paper
• High burden of invasive β-haemolytic streptococcal infections in Fiji

  2007influential reference
• Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic.

  2006cited by this paper
• The global burden of group A streptococcal diseases.

  2005influential reference
• Bacteremia among children admitted to a rural hospital in Kenya.

  2005influential reference
• Invasive group A streptococcal disease in North Queensland (1996 - 2001).

  2004influential reference
• Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial.

  2003cited by this paper
• Invasive streptococcal infections

  2001cited by this paper
• Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection.

  1999cited by this paper
• Epidemiology and prevention of group A streptococcal infections: acute respiratory tract infections, skin infections, and their sequelae at the close of the twentieth century.

  1999influential reference
• Clinical and epidemiological features of group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection

  1999influential reference
• EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients.

  1998cited by this paper
• Success of a scabies control program in an Australian aboriginal community.

  1997cited by this paper
• Clinical epidemiology of rheumatic fever and rheumatic heart disease in tropical Australia.

  1997cited by this paper
• Acute rheumatic fever and rheumatic heart disease in the Top End of Australia's Northern Territory

  1996cited by this paper
• The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure

  1996cited by this paper
• Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone.

  1995cited by this paper
• Report of renal failure treatment in Australia and New Zealand from the dialysis and transplant registry (ANZDATA)

  1995cited by this paper
• An epidemic of acute post‐streptococcal glomerulonephritis among Aboriginal children

  1995cited by this paper
• The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study.

  1993cited by this paper
• Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections.

  1993cited by this paper
• Definitions for sepsis and organ failure.

  1993cited by this paper
• Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

  1992cited by this paper
• The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis.

  1988cited by this paper
• Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis.

  1980cited by this paper
• 3. Sampling variance of standardized mortality rates.

  1966cited by this paper

• Prognostic factors in patients hospitalised with Group A Streptococcus bacteraemia in tropical Australia.

  2025cites this paper
• Bacteraemia in Tropical Australia: A Review

  2024cites this paper
• Acute Glomerulonephritis Following Systemic Scabies in Two Brothers

  2024cites this paper
• Presence of Streptococcus pyogenes in the throat in invasive Group A Streptococcal disease: a prospective two-year study in two health districts, Finland

  2023cites this paper
• Communicable Diseases Intelligence

  2023cites this paper
• Proteomic analysis of Sarcoptes scabiei reveals that proteins differentially expressed between eggs and female adult stages are involved predominantly in genetic information processing, metabolism and/or host-parasite interactions

  2022cites this paper
• Invasive group A streptococcal disease in pregnant women and young children: a systematic review and meta-analysis

  2022cites this paper
• The efficacy and safety of a shortened duration of antimicrobial therapy for Group A Streptococcus bacteraemia.

  2022cites this paper
• First Description of the Composition and the Functional Capabilities of the Skin Microbial Community Accompanying Severe Scabies Infestation in Humans

  2021cites this paper
• Understanding the role of the Scabies mite microbiota in the development of novel control strategies

  2021cites this paper
• Trends in Bacteremia Over 2 Decades in the Top End of the Northern Territory of Australia

  2020cites this paper
• Severe community-acquired pneumonia due to Streptococcus pyogenes in the Newcastle area.

  2020cites this paper
• Ectoparasites

  2020cites this paper
• Disparate Effects of Invasive Group A Streptococcus on Native Americans

  2020cites this paper
• High-quality nuclear genome for Sarcoptes scabiei—A critical resource for a neglected parasite

  2020cites this paper
• The Australian burden of invasive group A streptococcal disease: a narrative review

  2020cites this paper
• Infecciones por estreptococos y enterococos

  2020cites this paper
• Infections à streptocoques et entérocoques

  2019cites this paper
• Invasive disease due to Streptococcus pyogenes: Changes in incidence and prognostic factors

  2019cites this paper
• Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease

  2019cites this paper
• [Invasive disease due to Streptococcus pyogenes: Changes in incidence and prognostic factors].

  2019influential citation
• SToP (See, Treat, Prevent) skin sores and scabies trial: study protocol for a cluster randomised, stepped-wedge trial for skin disease control in remote Western Australia

  2019cites this paper
• Part I - Ectoparasites: Scabies.

  2019cites this paper
• An economic case for a vaccine to prevent group A streptococcus skin infections.

  2018cites this paper
• Are scabies and impetigo “normalised”? A cross-sectional comparative study of hospitalised children in northern Australia assessing clinical recognition and treatment of skin infections

  2017cites this paper
• The burden of invasive infections in critically ill Indigenous children in Australia

  2017cites this paper
• Prescribing for people with acute rheumatic fever.

  2017cites this paper
• Overview of Australian Aboriginal and Torres Strait Islander health status 2016

  2017cites this paper
• A Retrospective Case-Series of Children With Bone and Joint Infection From Northern Australia

  2016cites this paper
• High Incidence of Invasive Group A Streptococcal Infections in Remote Indigenous Communities in Northwestern Ontario, Canada

  2016influential citation
• Impetigo and scabies - Disease burden and modern treatment strategies.

  2016cites this paper
• A Retrospective case-series of children with bone and joint infection from northern

  2016cites this paper
• High burden of invasive group A streptococcal disease in the Northern Territory of Australia

  2015cites this paper